Esther Martinborough
Fortune : 180 650 $ au 31/07/2026
Fortune : 180 650 $ au 31/07/2026
Esther Martinborough is currently an Independent Director at Codexis, Inc. since 2021 and a Director at San Diego Squared since 2021.
Former positions include Chief Scientific Officer at Escient Pharmaceuticals, Inc. from 2023 to 2024 and Executive Director-Research at Receptos LLC from 2015 to 2018.
Education includes a doctorate from the Swiss Federal Institute of Technology and graduate studies at the University of California.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CODEXIS, INC. 0,12 % | 17/06/2026 | 129 036 ( 0,12 % ) | 180 650 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CODEXIS, INC. | Directeur/Membre du Conseil | 02/02/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Directeur Technique/Scientifique/R&D | 01/05/2024 |
| RECEPTOS INC | Directeur/Membre du Conseil | 01/01/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Codexis, Inc.
Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Receptos LLC
Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national